Skip navigation

Gilead Sciences Inc.

United States
Company NameGilead Sciences Inc.
Executive 1John Martin, Chairman; Chief Executive Officer;
Revenue (Millions)$9,703
Total Equity (Millions)$9,310
Net Income (Millions)$2,592
Revenue Growth15.71%
Profit Margin 126.71%
Earnings per Share$1.64
Debt to Equity Ratio0.78%
Return on Equity38.46%
Cost of Goods Sold (Millions)$2,471
Earnings per Share Growth(7.61%)
Total Assets (Millions)$21,240
Current Liabilities (Millions)$4,270
Long Term Debt (Millions)$7,283